Transcriptomic Analysis of Incisional Hernia Based on High-throughput Sequencing Technology
Completed
- Conditions
- Incisional HerniaExtracellular Matrix Alteration
- Interventions
- Diagnostic Test: Transcriptomic analysis
- Registration Number
- NCT06366581
- Lead Sponsor
- Fudan University
- Brief Summary
This study included patients who underwent surgical treatment for incisional hernia and non-hernia conditions. Surgical specimens were collected for transcriptome sequencing to obtain the gene expression list. Then genes analyzed by Gene Ontology, protein interactions, and signaling pathway enrichment using the expression matrix.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
1.18 to 75 years 2.diagnosed with incisional hernia 3.normal tumour markers 4.elective surgery patients.
Read More
Exclusion Criteria
- patients with vital organ failure (heart liver, lung, kidney and others)
- malignant tumors not been completely relieved by active treatment,
- patients who have psychiatric diseases or comprehension disorders.
- patients with metabolic disease involving connective tissue collagen.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description NC group Transcriptomic analysis patients who underwent laparoscopic cholecystectomy were defined as the control group (labelled as the NC group) IH group Transcriptomic analysis Patients who underwent incisional hernia repair were defined as the experimental group (labelled as the IH group)
- Primary Outcome Measures
Name Time Method the gene expression list 2023.3-2023.9 the gene expression list
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hua Dong Hospital Affiliated to Fu Dan University
🇨🇳Shanghai, China